Effect of Monoclonal Antibody Treatment on Clinical Outcomes in Ambulatory Patients With Coronavirus Disease 2019
Blake Anderson, Zirka Smith, Srilatha Edupuganti, Xiaobo Yan, Christopher M. Masi, Henry M. Wu
Abstract
We compared rates of emergency department visits or hospitalizations among ambulatory coronavirus disease 2019 (COVID-19) patients treated with monoclonal antibody (mAb) therapy (n = 305) vs untreated patients (n = 6354). Treatment was associated with decreased encounters within 30 days (adjusted odds ratio, 0.23 [95% confidence interval, .15-.36]). Our findings support treatment of acute COVID-19 with mAbs.
Topics & Concepts
MedicineAmbulatoryConfidence intervalOdds ratioInternal medicineCoronavirus disease 2019 (COVID-19)Monoclonal antibodyEmergency departmentCoronavirusDiseaseAntibodyImmunologyInfectious disease (medical specialty)PsychiatrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19